Legend Biotech Corp (LEGN) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
LEGN currently has 367M outstanding shares. with limited dilution risk as only 31.8M additional shares (8.7%) are authorized for issuance. The company has not diluted shareholders through share issuances in the past 2 years, which is positive for existing holders.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Mar 11, 2025 |
20-F filing | 367.3M shares outstanding |
370M | 32M |
| Mar 19, 2024 |
20-F filing | 363.8M shares outstanding |
360M | 32M |
| Mar 30, 2023 |
20-F filing | 330.1M shares outstanding |
330M | 32M |
| Mar 31, 2022 |
20-F filing | 308.5M shares outstanding |
310M | 32M |
| Jul 02, 2021 |
F-3 filing: This is an F-3 filing for the proposed resale or other disposition of up to an aggregate of 30,809,850 ordinary shares, of which (i) 20,809,850 are presently issued and outstanding and (ii) 10,000,000 are issuable upon the exercise of a warrant. |
21M | 32M |
| Apr 02, 2021 |
20-F filing | 266.0M shares outstanding |
270M | 1M |
| May 13, 2020 |
F-1 filing: This is an F-1 filing that includes information regarding a long-term incentive plan, company benefits, non-competition agreements, employment commencement date, at-will employment, offer confirmation and Legend Biotech Corporation share option scheme. |
N/A | 1M |